A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Rifaximin Vaginal Tablets in the Treatment of Bacterial Vaginosis
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Rifaximin (Primary) ; Metronidazole
- Indications Bacterial vaginosis
- Focus Therapeutic Use
- Acronyms VARIANT
- Sponsors Alfa Wassermann SpA
- 07 Oct 2016 Status changed from recruiting to discontinued.
- 17 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 Mar 2015 New trial record